0001213900-20-037060.txt : 20201113
0001213900-20-037060.hdr.sgml : 20201113
20201113210106
ACCESSION NUMBER: 0001213900-20-037060
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201111
FILED AS OF DATE: 20201113
DATE AS OF CHANGE: 20201113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: THURMAN RANDY H
CENTRAL INDEX KEY: 0001204059
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39102
FILM NUMBER: 201313359
MAIL ADDRESS:
STREET 1: 222 MERCHANDISE MART PLAZA
STREET 2: SUITE 2024
CITY: CHICAGO
STATE: IL
ZIP: 60654
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TFF Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001733413
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 824344737
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2600 VIA FORTUNA, SUITE 360
CITY: AUSTIN
STATE: TX
ZIP: 78746
BUSINESS PHONE: 737-802-1973
MAIL ADDRESS:
STREET 1: 2600 VIA FORTUNA, SUITE 360
CITY: AUSTIN
STATE: TX
ZIP: 78746
4
1
ownership.xml
OWNERSHIP DOCUMENT
X0306
4
2020-11-11
0
0001733413
TFF Pharmaceuticals, Inc.
TFFP
0001204059
THURMAN RANDY H
2600 VIA FORTUNA, SUITE 360
AUSTIN
TX
78746
1
0
0
0
Common Stock
2020-11-11
4
M
0
34504
2.50
A
39504
D
Common Stock
2020-11-11
4
S
0
34504
15.908
D
5000
D
Common Stock
2020-11-13
4
S
0
5000
17.173
D
0
D
Stock Options (Right to Buy)
2.50
2020-11-11
4
M
0
34504
0.00
D
2020-04-11
2029-04-11
Common Stock
34504
124925
D
The transactions reported by this Form 4 reflect the Reporting Person's exercise of options to purchase common shares pursuant to Rule 16b-3 under the Securities Exchange Act of 1934 and the Reporting Person's concurrent sale of the common shares acquired upon the exercise of the options.
23,003 shares of common stock vested on April 11, 2020 and the remainder of shares scheduled to vest at an approximate rate of 5,750 every three months thereafter.
/s/ Randy Thurman, by Kirk Allen Coleman, as Attorney-in-Fact
2020-11-13